Microbot Medical added to Russell Microcap Index effective June 30, 2025

Microbot Medical Inc.

Added to the Russell Microcap Index as of market open on June 30, 2025, with automatic inclusion in growth and value style indexes.
CEO Harel Gadot cited strong execution, ongoing FDA 510(k) submission for LIBERTY, and anticipated Q3 commercial launch.
Membership is based on market-cap rankings; Russell indexes serve as benchmarks for about $10.6 trillion in assets (June 2024).
Microbot Medical (MBOT) is a pre-commercial endovascular robotics developer; LIBERTY is pending FDA 510(k) clearance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.